Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Oncological Impact of the Level of Inferior Mesenteric Artery Ligation in Low Rectal Cancer Surgery

DAISUKE YOSHIDA, MASAHIKO SUGIYAMA, KENSUKE NAKAZONO, TABITO OYAMA, TAKUMI HASEGAWA, SEIICHIRO KAI, MANABU YAMAMOTO, TOSHIFUMI MATSUMOTO, HIROFUMI KAWANAKA, MASARU MORITA, YASUSHI TOH and TOKUJIRO YANO
Anticancer Research July 2023, 43 (7) 3225-3233; DOI: https://doi.org/10.21873/anticanres.16496
DAISUKE YOSHIDA
1Department of Surgery, Beppu Medical Center, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alfadai{at}pearl.ocn.ne.jp
MASAHIKO SUGIYAMA
2Department of Gastroenterological Surgery, National Kyushu Cancer Center, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENSUKE NAKAZONO
1Department of Surgery, Beppu Medical Center, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TABITO OYAMA
1Department of Surgery, Beppu Medical Center, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKUMI HASEGAWA
1Department of Surgery, Beppu Medical Center, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SEIICHIRO KAI
1Department of Surgery, Beppu Medical Center, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MANABU YAMAMOTO
2Department of Gastroenterological Surgery, National Kyushu Cancer Center, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOSHIFUMI MATSUMOTO
1Department of Surgery, Beppu Medical Center, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROFUMI KAWANAKA
1Department of Surgery, Beppu Medical Center, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASARU MORITA
2Department of Gastroenterological Surgery, National Kyushu Cancer Center, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUSHI TOH
2Department of Gastroenterological Surgery, National Kyushu Cancer Center, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOKUJIRO YANO
1Department of Surgery, Beppu Medical Center, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: This study aimed to evaluate the clinical impact of the level of inferior mesenteric artery (IMA) ligation in patients with advanced low rectal cancer. Patients and Methods: All enrolled patients (n=350) underwent curative resection of rectal cancer with D3 lymph node dissection, with either IMA (high-tie) or superior rectal artery (SRA) (low-tie) ligation. Results: There were 27 and 65 patients in the high-tie and low-tie groups, respectively. There was no significant difference in the postoperative complication rate. Postoperative anastomotic leakage developed in five patients in the low-tie group and none in the high-tie group. The overall recurrence rates were 37.0% (n=10) and 40.0% (n=26) in the high-tie and low-tie groups, respectively, with no significant difference between the two groups (p=0.748). Local recurrences and lymph node metastases developed in five and no patients in the high-tie group and in 13 and one patient in the low-tie group, respectively. In the multivariate analysis, pathological T4 and pathological N2 and N3 were independent poor prognostic factors for overall survival (OS), whereas left colic artery (LCA) preservation was not significant. Conclusion: No significant difference in oncological outcomes was observed in advanced low rectal cancer surgery with respect to the level of the IMA ligation. Thus, the less complicated high-tie procedure should be adopted as a standard procedure.

Key Words:
  • Rectal cancer
  • left colic artery
  • high-tie
  • low-tie
  • oncological outcome

In Japan, the morbidity of colorectal cancer (CRC) has increased sharply in the last 20 years, and the resulting mortality is the second highest, after lung cancer patients. Patients with rectal cancer have a slightly worse prognosis than those with CRC (1), and the importance of multimodal therapy, such as total neoadjuvant therapy (TNT), has been shown (2). Moreover, many surgeons believe that surgical treatment plays a pivotal role in improving the prognosis of patients with CRC.

In 1908, W.E. Miles reported an abdominoperineal resection procedure for rectal cancer (3), which incorporated the removal of lymphatic tissue. His study indicated complete eradication of the zone of ‘upward spread of cancer’ from the rectum, thereby diminishing the chance of disease recurrence. Around the same time, Moynihan proposed that when performing curative resection for rectal cancer (4), the inferior mesenteric artery (IMA), including the apical group of lymph nodes within the resection, should be resected at its origin. These were the pioneering studies that reported that lymph node dissection is a key factor in rectal cancer surgery and this principle is regarded as one of the most indispensable procedures.

Lymph node metastasis is a major prognostic factor for survival after surgery for rectal cancer. Guidelines by the Japanese Society for Cancer of the Colon and Rectum for the treatment of CRC recommend that proximal lymph node dissection should be performed, including the region around the root of the IMA, for advanced rectal cancer (clinical T2 or more) (1). Several studies have reported that positive lymph node metastasis at the root of the IMA in rectal cancer is relatively low (5-7), approximately 1%. However, Huh et al. found that the frequency of lymph node metastasis at the root of the IMA in sigmoid colon cancer and rectal cancer was 7.8% (8), which is not considered negligible as compared to the rate of lymph node metastasis.

Proximal spread along the superior rectal artery (SRA) is considered the principal route of lymphatic metastasis in rectal cancer, and the need to perform sufficient proximal lymph node dissection according to each clinical finding has been shown in several previous reports (6, 9, 10). Proximal lymph node dissection for rectal cancer is achieved with either IMA or SRA ligation (high-tie or low-tie), and the favorable outcomes of each technique have long been debated (11-14). Although various reports have evaluated the effects of the level of arterial ligation in rectal cancer on blood flow of anastomosis, autonomic nerve injury, reduction of the risk of anastomotic leakage, securing the bowel length, oncological outcomes, etc., it remains controversial whether the high-tie or low-tie procedure is more beneficial.

Especially in low rectal cancer surgery, all surgeons are anxious about the tension and blood flow supply at the anastomotic site, which is thought to be involved in anastomotic failure, as much as they are concerned about curability. Reducing postoperative complications and preserving anorectal function is important, but the most important task for any surgeon is to determine whether the surgical procedure can be safely completed without compromising the long-term outcomes. In the present study, we retrospectively evaluated the clinical impact of the level of the IMA ligation in patients with advanced low rectal cancer.

Patients and Methods

Patients and design. From January 2006 to April 2015, 350 consecutive patients with rectal cancer underwent surgical resection, and 191 patients were diagnosed with low rectal cancer, at the Department of Gastroenterological Surgery of the National Kyushu Cancer Center. Low rectal cancer was defined when the lower border of the tumor was located distal to the peritoneal reflection by colonoscopy and computed tomography. The exclusion criteria were as follows: (i) pathological Tis/T1 and node negative (n=51), (ii) synchronous distant metastasis (n=21), (iii) active or recent treatment for malignancy in another organ (n=19), (iv) histological types other than adenocarcinoma (n=2), and (v) lost perioperative data (n=6). A total of 92 advanced low rectal cancer patients were eligible for this retrospective study. After surgery, patients were followed up every 3 months for the first 3 years and every 6 months thereafter, according to the surveillance of Japanese guidelines (1). Informed consent was obtained from each patient before the operation, and their medical records were retrospectively reviewed. All procedures performed in this study involving human participants were in accordance with the ethical standards of the National Kyushu Cancer Center Institutional Review Board and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Surgery and assessment parameters. All patients enrolled in this study underwent curative resection of rectal cancer with D3 lymph node dissection, and IMA ligation (high-tie) and SRA ligation (low-tie) were selected according to each surgeon’s plan. In case of high-tie patients, the IMA was divided at its origin from the abdominal aorta (Figure 1A). In case of low-tie patients, the IMA was divided immediately after branching to the left colic artery (LCA), and lymph node dissection around the root of the IMA was performed (Figure 1B). To elucidate the clinical impact of IMA level in advanced low rectal cancer, we performed retrospective analyses evaluating patient demographics, clinicopathological data, operative information, short-term outcomes, and long-term outcomes. We focused on the following information: age, sex, body mass index (BMI), preoperative serum carcinoembryonic antigen (CEA) levels, preoperative serum albumin levels, surgical approach, type of resection, duration of surgery, estimated blood loss, pathological findings, postoperative complications defined as Clavien-Dindo classification (15), recurrence-free survival (RFS) rate, and overall survival (OS) rate. Furthermore, a postoperative complication was defined as an occurrence within 30 postoperative days. Anastomotic leakage was confirmed in the case of any feculent discharge from the drain at any time after surgery, any collection of purulent material in the pelvis by CT scan.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

The inferior mesenteric artery (IMA) was divided at its origin from the abdominal aorta with D3 lymph node dissection (high-tie, A). The IMA was divided immediately after branching to the left colic artery (LCA) with D3 lymph node dissection (low-tie, B). Ao: Abdominal aorta; SRA: superior rectal artery; SA: sigmoid artery.

Statistical analysis. All statistical analyses were performed using IBM SPSS Statistics version 28 (Chicago, IL, USA). Patient demographics, clinicopathological data, and operative information were evaluated using the chi-square test and Fisher’s exact test, as appropriate. Cumulative survival rates were calculated using the Kaplan–Meier method. Univariate and multivariate analyses were performed using the Cox proportional hazards model to assess associations between the level of IMA ligation and RFS/OS rate. All variables that were significantly associated in the univariate analysis were included in the multivariate analysis. All tests were two-sided, and statistical significance was set at p<0.05.

Results

A flow chart of all patients enrolled in the analyses is shown in Figure 2. The 92 patients undergoing curative resection were enrolled. There were 27 patients in the high-tie group and 65 patients in the low-tie group. Patient demographics, clinicopathological data, and operative information for both groups are shown in Table I. Serum albumin levels were significantly lower in the high-tie group (p=0.020), and there were also significant differences in the surgical approach and type of resection between the groups (p=0.014). Nine patients underwent neoadjuvant therapy. Seven patients received chemoradiotherapy and two patients received chemotherapy only. No patients received TNT. Patients who received chemoradiation were treated with 45 Gy in 25 fractions, and S-1 was administered. Patients who received chemotherapy alone received the FOLFOX regimen for 2-4 months.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Flow chart of patient selection. LCA: Left colic artery.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Patient demographics, clinicopathological data, and operative information.

Pathological findings showed that the number of lymph nodes harvested was significantly higher and the number of patients with lymphatic invasion was significantly lower in the high-tie group. However, there was no significant difference in the final pathological stage between the two groups. The number of patients with pathological stage III low rectal cancer was 21 (77.8%) in the high-tie group and 50 (76.9%) in the low-tie group.

Postoperative complications and recurrence. There was no significant difference in the postoperative complication rate, and postoperative anastomotic leakage developed in five patients in the low-tie group and none in the high-tie group (p=0.138). However, anastomosis was performed in five patients in the high-tie group and 46 patients in the low-tie group, and diverting ileostomy was performed in five patients (100%) and 37 patients (80.4%), respectively. However, there were no significant differences in surgical site infection (22.2% vs. 21.5%, p=0.942), bowel obstruction (7.4% vs. 3.1%, p=0.354), or urinary dysfunction (11.1% vs. 18.5%, p=0.385) between the two groups.

The overall recurrence rate was 37.0% (n=10) in the high-tie group and 40.0% (n=26) in the low-tie group, with no significant difference between the two groups (p=0.748). Local recurrences and lymph node metastases developed in five and no patients in the high-tie group and in 13 and one patient in the low-tie group, respectively. There was no significant difference in the follow-up period between the two groups (Table II).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Postoperative complications.

Prognostic factors for low rectal cancer. Univariate and multivariate analyses of prognostic factors for RFS and OS in patients with low rectal cancer are shown in Table III and Table IV, respectively. Univariate analyses showed that pathological N2, N3 (p<0.001) was the only significant association with poorer RFS after curative surgery, and open surgery (p=0.025), estimated blood loss ≥200 (p=0.029), pathological T4 (p=0.003), pathological N2, N3 (p=0.009), and presence of lymphatic invasion (p=0.009) were significantly associated with poorer OS after curative surgery.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Risk factors associated with recurrence-free survival.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table IV.

Risk factors associated with overall survival.

In the multivariate Cox proportional hazards analysis, only two factors, pathological T4 and pathological N2 and N3, were independent poor prognostic factors for OS, whereas LCA preservation, CEA≥5, operative procedure, postoperative complication grading, lymphatic invasion, and venous invasion were not significant.

Long-term outcomes according to the level of IMA ligation. On Kaplan–Meier analysis, the 5-year RFS rates for the high-tie and low-tie groups were 50.7% and 56.3%, respectively, with no statistically significant difference between the two groups (p=0.985) (Figure 3A). In contrast, the 5-year OS rates for the high-tie and low-tie groups were 78.2% and 68.0%, respectively. Although there was no statistically significant difference with respect to the level of IMA ligation (p=0.249), the high-tie group had prolonged OS by approximately 10% (Figure 3B). Moreover, when restricted to node-positive patients only, the high-tie group had an approximately 13% improved 5-year OS rate compared to the low-tie group (76.9% vs. 63.8%, p=0.265), although no significant difference was observed.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Kaplan–Meier survival analysis comparing high-tie (solid line) and low-tie (dashed line) in respect to recurrence-free survival (A) and overall survival (B).

Discussion

In rectal cancer surgery, every surgeon is sufficiently concerned about perioperative complications such as anastomotic blood supply, anastomotic tension, preservation of the autonomic nervous system, as well as oncological outcomes. Notably, the clinical impact with respect to the level of IMA ligation has been previously considered, but there seems to be a lack of a clinical consensus. Although several studies have focused on the level of ligation of the IMA in rectal cancer surgery, the details of the clinical outcomes of IMA ligation level limited to advanced low rectal cancer have not been described in the literature to date. Therefore, we focused on the clinical and oncological impact of IMA ligation in advanced low rectal cancer.

Hinoi et al. (16) retrospectively evaluated the clinical significance of LCA preservation in middle and low rectal cancer surgery at the Japan Society of Laparoscopic Colorectal Surgery. Although this study was a retrospective study, a multicenter study across Japan showed that preservation of the LCA in laparoscopic anterior resection for middle and low rectal cancers was associated with a lower anastomotic leakage rate. There was no significant difference in survival rates between the two groups with radical resection. In contrast, a Japanese single-center randomized control trial showed that LCA preservation in rectal cancer surgery was not associated with anastomotic leakage, and there was no significant difference in long-term outcomes (17). Therefore, they concluded that it is better to treat high-tie as a standard procedure than technically complex low-tie with dissection around the root of the IMA.

We believe that the IMA ligation (high-tie) is technically easier to perform than the SRA ligation (low-tie) using the avascular windows superior and inferior to the IMA and inferior mesenteric vein. The low-tie with D3 lymph node dissection is a complicated procedure, whether open or laparoscopic, because lymph nodes at the root of the IMA must be dissected en-bloc.

Another consideration in regards to high versus low tie is genitourinary dysfunction. In the HIGHLOW trial, in which genitourinary dysfunction due to the level of IMA ligation was evaluated as the primary outcome, it was shown that the low-tie group had better genitourinary function preservation (13). Mari et al. suggested that arterial ligation far from the hypogastric plexus could help preserve pelvic autonomic functions, resulting in a better quality of life of patients. Other studies also showed that low-tie may provide improved blood supply to the proximal end of the anastomosis and reduce the risk of autonomic nerve injury (18, 19). In our study, genitourinary dysfunction was not significantly observed in the high-tie group. We believe that visualization of the nervous system, including the lumbar splanchnic nerve, leads to the preservation of genitourinary function.

In a recent meta-analysis (20), no difference was found between the high-tie and low-tie of the IMA in rectal cancer surgery in terms of lymph node yield and postoperative morbidity and mortality outcomes. These analyses indicate that long-term survival outcomes are under investigation and depend on future randomized trials. To the best of our knowledge, there are no reports of improved oncologic prognosis with low-tie as compared to high-tie in rectal cancer surgery.

The data collected in this study show a statistically significant difference between serum albumin and surgical approach, which likely influenced the level of IMA ligation. This decision is left to the discretion of each surgeon. Importantly, there was no statistically significant difference in postoperative complications between LCA ligation levels in advanced low rectal cancer surgery. However, the number of patients requiring anastomosis in the high-tie and low-tie groups was five (18.5%) and 46 (70.8%), respectively, and diverting ileostomy was performed in 100% and 80.4% of the patients, respectively. Thus, it can be considered that sufficient comparative results of the anastomotic leakage rate have not been analyzed. However, major complications other than suture failure were not significantly different between the two groups. In particular, urinary dysfunction occurred in 5% and 7% of patients in the high-tie and low-tie groups, respectively, and the surgical procedure of lymph node dissection around the root of the IMA did not adversely affect autonomic nervous system preservation. In contrast, the local recurrence rates were 18.5% and 20.0% for the high-tie and low-tie groups, respectively, with no significant difference. Regarding long-term outcomes, our findings underscore the fact that the level of IMA ligation is not a predictor for recurrence and survival, and no significant difference was observed between the two groups in both 5-year RFS and OS rates.

In 2000, the National Cancer Institute sponsored a panel of experts to systematically review the current literature and to draft guidelines that provide uniform definitions, principles, and practices. They showed that although the level of evidence is weak, the recommended level of proximal vascular ligation for rectal cancer is at the origin of the SMA. This recommendation is based on the same data used to indicate primary feeding vessel ligation for colon cancer (21). In addition, several previous studies have recommended low-tie in terms of blood flow to the anastomotic site and autonomic nerve injury (14, 22). In Japan, exploratory analyses using data from JCOG0404 (23) investigated the clinical impact with respect to the level of ligation of the IMA. Akagi et al. showed that oncological outcomes were better in D3 dissection with LCA preservation than in D3 dissection without LCA preservation, although this study targeted patients with stage II-III sigmoid and rectosigmoid colon cancer (24). Nevertheless, a previous study has advocated the principal concept that the tumor-bearing specimen should be harvested as an enveloped package to minimize the risk of tumor cell spillage and local recurrence (25). Culligan et al. indicated that inadequate resection of the mesocolon is associated with adverse outcomes in colon cancer (26). In CRC surgery, it is considered desirable to perform lymph node dissection according to the staging while maintaining the integrity of the mesenteric lymphatic package (27, 28). Therefore, a low-tie with lymph node dissection around the root of the IMA for advanced low rectal cancer may be associated with the risk of tumor cell spillage and local recurrence. Although our study did not reveal a significant difference, we believe that the ligation of the root of the IMA may improve long-term oncological outcomes in curative resection of stage II-III rectal cancer.

This study has several limitations. First, this study was a retrospective evaluation with a small number of patients analyzed at a single center. Therefore, the preference for surgical techniques may have affected the oncological outcomes. Second, there is a possibility of selection bias due to differences in the patients who underwent preoperative and postoperative treatments. However, these perioperative treatments were not identified as prognostic factors in the multivariate analyses. Finally, although lymph node dissection of the root of the IMA was performed in every patient, the surgeon decided whether to preserve the LCA or not. Each surgeon may decide whether or not to preserve the LCA by preoperative diagnosis.

In conclusion, the present study showed no significant difference in oncological outcomes in advanced low rectal cancer surgery with the respect to the level of IMA ligation. We believe that the high-tie procedure should be adopted as a standard procedure in advanced low rectal cancer rather than the low-tie procedure, which is a technically complicated procedure. Especially for patients strongly suspected of having regional lymph node metastasis, we believe that the high-tie procedure may provide better long-term oncological outcomes. The necessity for a randomized trial is mandatory to assess oncological outcomes with respect to the level of IMA ligation in low anterior resection and intersphincteric resection for advanced low rectal cancer.

Acknowledgements

The Authors would like to thank Editage (www.editage.com) for English language editing.

Footnotes

  • Authors’ Contributions

    D.Y. and M.S. contributed to the conception and design of the study, data collection, data analysis, and manuscript writing. K.N., T.O., T.H., S.K., T.M., M.Y., and M.M. provided critical revisions that were important for the intellectual content. H.K., Y.T., and T.Y. approved the final version of the manuscript.

  • Conflicts of Interest

    The Authors declare that they have no conflicts of interest in relation to this study.

  • Received April 17, 2023.
  • Revision received May 6, 2023.
  • Accepted May 8, 2023.
  • Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

References

  1. ↵
    1. Hashiguchi Y,
    2. Muro K,
    3. Saito Y,
    4. Ito Y,
    5. Ajioka Y,
    6. Hamaguchi T,
    7. Hasegawa K,
    8. Hotta K,
    9. Ishida H,
    10. Ishiguro M,
    11. Ishihara S,
    12. Kanemitsu Y,
    13. Kinugasa Y,
    14. Murofushi K,
    15. Nakajima TE,
    16. Oka S,
    17. Tanaka T,
    18. Taniguchi H,
    19. Tsuji A,
    20. Uehara K,
    21. Ueno H,
    22. Yamanaka T,
    23. Yamazaki K,
    24. Yoshida M,
    25. Yoshino T,
    26. Itabashi M,
    27. Sakamaki K,
    28. Sano K,
    29. Shimada Y,
    30. Tanaka S,
    31. Uetake H,
    32. Yamaguchi S,
    33. Yamaguchi N,
    34. Kobayashi H,
    35. Matsuda K,
    36. Kotake K,
    37. Sugihara K, Japanese Society for Cancer of the Colon and Rectum
    : Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25: 1-42, 2020. DOI: 10.1007/s10147-019-01485-z
    OpenUrlCrossRefPubMed
  2. ↵
    1. Petrelli F,
    2. Trevisan F,
    3. Cabiddu M,
    4. Sgroi G,
    5. Bruschieri L,
    6. Rausa E,
    7. Ghidini M,
    8. Turati L
    : Total neoadjuvant therapy in rectal cancer. Annals of Surgery 271(3): 440-448, 2021. DOI: 10.1097/SLA.0000000000003471
    OpenUrlCrossRef
  3. ↵
    1. Miles W
    : A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon (1908). CA: A Cancer Journal for Clinicians 21(6): 361-364, 2018. DOI: 10.3322/canjclin.21.6.361
    OpenUrlCrossRef
  4. ↵
    1. Moynihan BGA
    : The surgical treatment of cancer of the sigmoid flexure and rectum. Surg Gynecol Obstet 6: 463, 1908.
    OpenUrl
  5. ↵
    1. Adachi Y,
    2. Inomata M,
    3. Miyazaki N,
    4. Sato K,
    5. Shiraishi N,
    6. Kitano S
    : Distribution of lymph node metastasis and level of inferior mesenteric artery ligation in colorectal cancer. Journal of Clinical Gastroenterology 26(3): 179-182, 2021. DOI: 10.1097/00004836-199804000-00006
    OpenUrlCrossRef
  6. ↵
    1. Kanemitsu Y,
    2. Hirai T,
    3. Komori K,
    4. Kato T
    : Survival benefit of high ligation of the inferior mesenteric artery in sigmoid colon or rectal cancer surgery. British Journal of Surgery 93(5): 609-615, 2021. DOI: 10.1002/bjs.5327
    OpenUrlCrossRef
  7. ↵
    1. Uehara K,
    2. Yamamoto S,
    3. Fujita S,
    4. Akasu T,
    5. Moriya Y
    : Impact of upward lymph node dissection on survival rates in advanced lower rectal carcinoma. Digestive Surgery 24(5): 375-381, 2022. DOI: 10.1159/000107779
    OpenUrlCrossRef
  8. ↵
    1. Huh J,
    2. Kim Y,
    3. Kim H
    : Distribution of lymph node metastases is an independent predictor of survival for sigmoid colon and rectal cancer. Annals of Surgery 255(1): 70-78, 2021. DOI: 10.1097/SLA.0b013e31823785f6
    OpenUrlCrossRef
  9. ↵
    1. Kim J,
    2. Sohn D,
    3. Park J,
    4. Kim D,
    5. Chang H,
    6. Choi H,
    7. Oh J
    : Prognostic significance of distribution of lymph node metastasis in advanced mid or low rectal cancer. Journal of Surgical Oncology 104(5): 486-492, 2021. DOI: 10.1002/jso.21966
    OpenUrlCrossRef
  10. ↵
    1. Hu S,
    2. Li S,
    3. Teng D,
    4. Yan Y,
    5. Lin H,
    6. Liu B,
    7. Gao Z,
    8. Zhu S,
    9. Wang Y,
    10. Du X
    : Analysis of risk factors and prognosis of 253 lymph node metastasis in colorectal cancer patients. BMC Surgery 21(1): 280, 2021. DOI: 10.1186/s12893-021-01276-2
    OpenUrlCrossRefPubMed
  11. ↵
    1. Pezim ME,
    2. Nicholls RJ,
    3. Chir M
    : Survival after high or low ligation of the inferior mesenteric artery during curative surgery for rectal cancer. Ann Surg 200: 729-733, 1984. DOI: 10.1097/00000658-198412000-00010
    OpenUrlCrossRefPubMed
    1. Fujii S,
    2. Ishibe A,
    3. Ota M,
    4. Watanabe K,
    5. Watanabe J,
    6. Kunisaki C,
    7. Endo I
    : Randomized clinical trial of high versus low inferior mesenteric artery ligation during anterior resection for rectal cancer. BJS Open 2(4): 195-202, 2021. DOI: 10.1002/bjs5.71
    OpenUrlCrossRef
  12. ↵
    1. Mari G,
    2. Crippa J,
    3. Cocozza E,
    4. Berselli M,
    5. Livraghi L,
    6. Carzaniga P,
    7. Valenti F,
    8. Roscio F,
    9. Ferrari G,
    10. Mazzola M,
    11. Magistro C,
    12. Origi M,
    13. Forgione A,
    14. Zuliani W,
    15. Scandroglio I,
    16. Pugliese R,
    17. Costanzi A,
    18. Maggioni D
    : Low ligation of inferior mesenteric artery in laparoscopic anterior resection for rectal cancer reduces genitourinary dysfunction. Annals of Surgery 269(6): 1018-1024, 2021. DOI: 10.1097/SLA.0000000000002947
    OpenUrlCrossRef
  13. ↵
    1. Turgeon M,
    2. Gamboa A,
    3. Regenbogen S,
    4. Holder-Murray J,
    5. Abdel-Misih S,
    6. Hawkins A,
    7. Silviera M,
    8. Maithel S,
    9. Balch G
    : A US Rectal Cancer Consortium study of inferior mesenteric artery versus superior rectal artery ligation: how high do we need to go? Diseases of the Colon & Rectum 64(10): 1198-1211, 2021. DOI: 10.1097/DCR.0000000000002052
    OpenUrlCrossRefPubMed
  14. ↵
    1. Dindo D,
    2. Demartines N,
    3. Clavien P
    : Classification of surgical complications. Annals of Surgery 240(2): 205-213, 2021. DOI: 10.1097/01.sla.0000133083.54934.ae
    OpenUrlCrossRef
  15. ↵
    1. Hinoi T,
    2. Okajima M,
    3. Shimomura M,
    4. Egi H,
    5. Ohdan H,
    6. Konishi F,
    7. Sugihara K,
    8. Watanabe M
    : Effect of left colonic artery preservation on anastomotic leakage in laparoscopic anterior resection for middle and low rectal cancer. World Journal of Surgery 37(12): 2935-2943, 2019. DOI: 10.1007/s00268-013-2194-3
    OpenUrlCrossRef
  16. ↵
    1. Fujii S,
    2. Ishibe A,
    3. Ota M,
    4. Suwa H,
    5. Watanabe J,
    6. Kunisaki C,
    7. Endo I
    : Short-term and long-term results of a randomized study comparing high tie and low tie inferior mesenteric artery ligation in laparoscopic rectal anterior resection: subanalysis of the HTLT (High tie vs. low tie) study. Surgical Endoscopy 33(4): 1100-1110, 2019. DOI: 10.1007/s00464-018-6363-1
    OpenUrlCrossRefPubMed
  17. ↵
    1. Surtees P,
    2. Ritchie J,
    3. Phillips R
    : High versus low ligation of the inferior mesenteric artery in rectal cancer. British Journal of Surgery 77(6): 618-621, 2021. DOI: 10.1002/bjs.1800770607
    OpenUrlCrossRef
  18. ↵
    1. Corder A,
    2. Karanjia N,
    3. Williams J,
    4. Heald R
    : Flush aortic tie versus selective preservation of the ascending left colic artery in low anterior resection for rectal carcinoma. British Journal of Surgery 79(7): 680-682, 2021. DOI: 10.1002/bjs.1800790730
    OpenUrlCrossRef
  19. ↵
    1. Hajibandeh S,
    2. Hajibandeh S,
    3. Maw A
    : Meta-analysis and trial sequential analysis of randomized controlled trials comparing high and low ligation of the inferior mesenteric artery in rectal cancer surgery. Diseases of the Colon & Rectum 63(7): 988-999, 2021. DOI: 10.1097/DCR.0000000000001693
    OpenUrlCrossRef
  20. ↵
    1. Nelson H,
    2. Petrelli N,
    3. Carlin A,
    4. Couture J,
    5. Fleshman J,
    6. Guillem J,
    7. Miedema B,
    8. Ota D,
    9. Sargent D
    : Guidelines 2000 for colon and rectal cancer surgery. JNCI Journal of the National Cancer Institute 93(8): 583-596, 2021. DOI: 10.1093/jnci/93.8.583
    OpenUrlCrossRef
  21. ↵
    1. Lange M,
    2. Buunen M,
    3. van de Velde C,
    4. Lange J
    : Level of arterial ligation in rectal cancer surgery: low tie preferred over high tie. A review. Diseases of the Colon & Rectum 51(7): 1139-1145, 2021. DOI: 10.1007/s10350-008-9328-y
    OpenUrlCrossRef
  22. ↵
    1. Yamamoto S,
    2. Inomata M,
    3. Katayama H,
    4. Mizusawa J,
    5. Etoh T,
    6. Konishi F,
    7. Sugihara K,
    8. Watanabe M,
    9. Moriya Y,
    10. Kitano S
    : Short-term surgical outcomes from a randomized controlled trial to evaluate laparoscopic and open D3 dissection for stage II/III colon cancer. Annals of Surgery 260(1): 23-30, 2021. DOI: 10.1097/SLA.0000000000000499
    OpenUrlCrossRef
  23. ↵
    1. Akagi T,
    2. Inomata M,
    3. Hara T,
    4. Mizusawa J,
    5. Katayama H,
    6. Shida D,
    7. Ohue M,
    8. Ito M,
    9. Kinugasa Y,
    10. Saida Y,
    11. Masaki T,
    12. Yamamoto S,
    13. Hanai T,
    14. Yamaguchi S,
    15. Watanabe M,
    16. Sugihara K,
    17. Fukuda H,
    18. Kanemitsu Y,
    19. Kitano S
    : Clinical impact of D3 lymph node dissection with left colic artery (LCA) preservation compared to D3 without LCA preservation: Exploratory subgroup analysis of data from JCOG0404. Annals of Gastroenterological Surgery 4(2): 163-169, 2023. DOI: 10.1002/ags3.12318
    OpenUrlCrossRef
  24. ↵
    1. Kessler H,
    2. Hohenberger W
    : Extended lymphadenectomy in colon cancer is crucial. World Journal of Surgery 37(8): 1789-1798, 2020. DOI: 10.1007/s00268-013-2130-6
    OpenUrlCrossRef
  25. ↵
    1. Culligan K,
    2. Sehgal R,
    3. Mulligan D,
    4. Dunne C,
    5. Walsh S,
    6. Quondamatteo F,
    7. Dockery P,
    8. Coffey J
    : A detailed appraisal of mesocolic lymphangiology – an immunohistochemical and stereological analysis. Journal of Anatomy 225(4): 463-472, 2021. DOI: 10.1111/joa.12219
    OpenUrlCrossRef
  26. ↵
    1. Enker W
    : Total mesorectal excision — The new golden standard of surgery for rectal cancer. Annals of Medicine 29(2): 127-133, 2017. DOI: 10.3109/07853899709113698
    OpenUrlCrossRef
  27. ↵
    1. Hohenberger W,
    2. Weber K,
    3. Matzel K,
    4. Papadopoulos T,
    5. Merkel S
    : Standardized surgery for colonic cancer: complete mesocolic excision and central ligation - technical notes and outcome. Colorectal Disease 11(4): 354-364, 2021. DOI: 10.1111/j.1463-1318.2008.01735.x
    OpenUrlCrossRef
PreviousNext
Back to top

In this issue

Anticancer Research: 43 (7)
Anticancer Research
Vol. 43, Issue 7
July 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Oncological Impact of the Level of Inferior Mesenteric Artery Ligation in Low Rectal Cancer Surgery
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Oncological Impact of the Level of Inferior Mesenteric Artery Ligation in Low Rectal Cancer Surgery
DAISUKE YOSHIDA, MASAHIKO SUGIYAMA, KENSUKE NAKAZONO, TABITO OYAMA, TAKUMI HASEGAWA, SEIICHIRO KAI, MANABU YAMAMOTO, TOSHIFUMI MATSUMOTO, HIROFUMI KAWANAKA, MASARU MORITA, YASUSHI TOH, TOKUJIRO YANO
Anticancer Research Jul 2023, 43 (7) 3225-3233; DOI: 10.21873/anticanres.16496

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Oncological Impact of the Level of Inferior Mesenteric Artery Ligation in Low Rectal Cancer Surgery
DAISUKE YOSHIDA, MASAHIKO SUGIYAMA, KENSUKE NAKAZONO, TABITO OYAMA, TAKUMI HASEGAWA, SEIICHIRO KAI, MANABU YAMAMOTO, TOSHIFUMI MATSUMOTO, HIROFUMI KAWANAKA, MASARU MORITA, YASUSHI TOH, TOKUJIRO YANO
Anticancer Research Jul 2023, 43 (7) 3225-3233; DOI: 10.21873/anticanres.16496
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Prognosis of Inferior Mesenteric and Para-aortic Lymph Node Metastases in Rectal Cancer: A Multicenter Study
  • Google Scholar

More in this TOC Section

  • Real-world Analysis of Treatment Patterns, Clinical Outcomes, and Molecular Profiling in Advanced Biliary Tract Cancer
  • Post-progression Nutritional and Immune Status Determines Survival After First-line Chemotherapy in Unresectable Advanced Gastric Cancer
  • Factors Associated With Nonadherence to S-1 in Docetaxel+S-1(DS) Therapy, an Adjuvant Treatment for Gastric Cancer
Show more Clinical Studies

Keywords

  • Rectal cancer
  • left colic artery
  • high-tie
  • low-tie
  • oncological outcome
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire